Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Inkef, also known as INKEF Capital, is an Amsterdam-based early-stage venture capital firm founded to invest in technology and healthcare/life-science companies. Established with a vision to support startups through various development stages, Inkef emphasizes a long-term partnership approach. The firm manages a fund size of €500 million, allowing it to provide substantial support to its portfolio companies.
Currently, Inkef operates with a team of 10 professionals, including partners and associates, who bring a wealth of experience in venture capital and entrepreneurship. The firm primarily focuses on European startups, aiming to help them achieve global success. Inkef's commitment to being a hands-on investor is evident in its active involvement in the growth journey of its portfolio companies.
Inkef primarily invests in early-stage technology and healthcare companies, with a strong emphasis on Series A investments. The firm is open to providing seed capital for exceptional teams and can also offer growth capital to support promising startups. The sectors of interest include healthcare, biotech, fintech, SaaS, and digital health, reflecting Inkef's commitment to fostering innovation in both technology and life sciences.
Inkef seeks to partner with companies that demonstrate potential for international growth. The firm values deep technical or scientific differentiation in its investments and prefers to engage with founders who have a credible path to scaling their businesses globally. This hands-on approach allows Inkef to provide strategic guidance and operational support throughout the development stages of its portfolio companies.
Inkef's portfolio includes a diverse range of companies across various sectors, showcasing its investment strategy in technology and healthcare. Notable portfolio companies include:
This diverse portfolio reflects Inkef's strategy of investing in companies with the potential for significant impact in their respective fields.
Corné Jansen - Partner. Corné has extensive experience in the Dutch startup ecosystem and has been involved in various successful investments.
Frank Lansink - Partner. Frank is a seasoned investor with a strong background in venture capital and entrepreneurship.
Thijs Cohen Tervaert - Partner. Thijs brings expertise in technology investments and has a track record of supporting startups through their growth phases.
Ivan Burkov - Partner. Ivan has a focus on RNA medicine investments and is actively engaged in discussions around innovative healthcare solutions.
Ryan Sarver - Venture Partner. Ryan is involved in founder and operator tooling and has a strong network within the tech community.
Carien Nantois-Beijer - Principal. Carien plays a key role in sourcing and evaluating potential investments.
Cher Shen Kiar - Senior Associate. Cher supports the investment team in due diligence and portfolio management.
Reitze Douma - Partner, COO. Reitze oversees operational aspects of the firm and contributes to strategic decision-making.
Kirsten Abma - Marketing Director. Kirsten manages marketing efforts and enhances Inkef's visibility in the venture capital space.
Mirella Tempelaars - Operations Manager. Mirella ensures smooth operational processes within the firm.
To pitch Inkef, founders should submit their proposals through the official website. A detailed pitch deck is essential, including information on the business model, market analysis, team background, and financial projections. While specific response times are not disclosed, founders can expect a thorough review process.
Warm introductions are preferred, as they can facilitate a more favorable reception of the pitch. Founders are encouraged to highlight any unique aspects of their business that align with Inkef's investment focus on technology and healthcare.
In March 2026, Inkef participated in Silverflow's $40 million Series B funding round, demonstrating its ongoing commitment to supporting its portfolio companies. This investment reflects Inkef's strategy of backing companies with strong growth potential in the technology sector.
Additionally, Inkef continues to engage with its portfolio companies, including NMD Pharma and Quantum Motion, highlighting its active involvement in the growth journeys of these firms. The firm remains focused on identifying and supporting innovative startups in the technology and healthcare sectors.
What are Inkef's investment criteria?
Inkef primarily invests in early-stage technology and healthcare companies, focusing on Series A rounds. The firm is open to seed capital for exceptional teams and can provide growth capital for promising startups.
How can I pitch to Inkef?
Founders can reach out to Inkef through their official website. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential.
What makes Inkef different from other investors?
Inkef emphasizes a hands-on approach, providing strategic guidance and operational support to its portfolio companies. The firm aims to be a long-term partner throughout the growth journey.
What is Inkef's geographic focus?
Inkef primarily focuses on European startups but aims to support companies with potential for international growth.
What is the typical check size for investments?
While specific check sizes are not disclosed, Inkef's fund size of €500 million allows for substantial investments in early-stage companies.
What kind of post-investment involvement does Inkef have?
Inkef actively engages with its portfolio companies, providing mentorship, strategic guidance, and access to its extensive network to help them navigate their growth journey.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.